In this photo illustration, the American multinational pharmaceutical corporation Pfizer logo is seen displayed on a smartphone with an economic stock exchange index graph in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images)
Pfizer has entered a $43 billion merger agreement with biotechnology firm Seagen. The deal is designed to bolster the pharmaceutical giant's efforts to fight cancer by scaling up the production of a promising antibody drug.
“Pfizer is deploying its financial resources to advance the battle against cancer, a leading cause of death worldwide with a significant impact on public health,” said CEO Dr. Albert Bourla.
“Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate (ADC) technology with the scale and strength of Pfizer’s capabilities and expertise."
ADCs are designed to kill cancer cells and limit off-target toxicities. Bourla noted that oncology is the "largest growth driver in global medicine," and that the deal would improve Pfzier's position in the space.
Seagen forecast $2.2 billion in revenue in 2023, up 12 percent from last year. Pfizer said the company could contribute $10 billion in risk-adjusted revenues by 2030. This would supplement the company's existing oncology division, which brought in $12 billion in revenue in 2022 with a combination of prostate cancer and the breast cancer treatments.
“Pfizer shares our steadfast commitment to patients, and this combination is a testament to the passion, dedication and talent of the Seagen team to achieve our mission to discover, develop, and commercialize transformative cancer medicines that make a meaningful difference in people’s lives,” said Seagan CEO David Epstein.
Twitter is planning to pivot to video content, according to Reuters. Cheddar News explains how the tech giant looks to double down on video, creative and e-commerce strategies.
Whether it's a gym membership, a cell phone contract, or an extended warranty, getting locked into a bad contract can be frustrating and very costly. So we wanted to share some advice to avoid potential risks involved. Let's take a look.
Multiple U.S. owners of Hyundai's popular Ioniq 5 electric SUV have complained of completely or partially losing propulsive power, many after hearing a loud popping noise, the National Highway Traffic Safety Administration said Saturday.
Ford Executive Chairman Bill Ford told CNN's 'Fareed Zakaria that despite recent gains the U.S. was still not in a position to compete with China in the production of electric vehicles.
Global stock markets followed Wall Street lower Monday after the top U.S. diplomat met China's leader but the two sides gave no sign of progress on an array of conflicts.
Supergoop! is a skincare brand whose products are what the company says is 100% dedicated to sun care. Amanda Baldwin, CEO of Supergoop!, joined Cheddar News to discuss why sunscreen is important to add to daily routines. "What I love about this company is ... it really is based on scientific fact," Baldwin said. "90% of the signs of aging comes from the sun ... one in five of us will be diagnosed with skin cancer in our lifetime so making sunscreen a daily habit is probably one of the most simple things you can do for your health."
College enrollment rates for high school graduates in the U.S. has been on the decline since 2009. Sean Behr, CEO of Fountain a high-volume hiring platform, joined Cheddar News to discuss why high school graduates are benefitting from the value of attending a trade school, especially in today's economy.
